Loading Video...
NTHRYS
Arrow

PBPK/PD Modeling Fundamentals for Drug Development | IVIVE, PopPK & Simulation-Driven Dosing

NTHRYS >> Services >> Academic Services >> Training Programs >> Bioinformatics Training >> Cheminformatics, QSAR & ADMET >> PBPK/PD Modeling Fundamentals for Drug Development | IVIVE, PopPK & Simulation-Driven Dosing

PBPK/PD Modeling — Hands-on

Learn end-to-end PBPK/PD modeling to translate in vitro and preclinical findings into clinically relevant predictions. This hands-on module covers compartmental vs PBPK structures, IVIVE and allometric scaling, parameter estimation (nonlinear mixed effects) , covariate modeling, and simulation-based decision making for dose and regimen selection — delivered as reproducible workflows.

PBPK/PD Modeling Fundamentals for Drug Development
Help Desk · WhatsApp
Session 1
Fee: Rs 19800
PK/PD Basics, Data & Assumptions
  • Core concepts & study designs
  • PK vs PD, exposure–response noncompartmental analysis (NCA) sampling designs & BLQ handling
  • Data requirements & QC
  • concentration–time, bioanalytical QC units & dosing records EDA & outlier strategy
  • Toolchain
  • R (nlmixr2/mrgsolve) Stan/TMB PK-Sim/OSPSuite
Session 2
Fee: Rs 22800
Compartmental vs PBPK & IVIVE
  • Structural model choices
  • one/two-compartment (+ effect site) PBPK organ flows/volumes permeability & binding
  • Scaling & IVIVE
  • allometry (CL, V) in vitro → in vivo (microsomes/hepatocytes) first-pass & absorption models
  • PD link models
  • Emax/sigmoid Emax indirect response models turnover & transit compartments
Session 3
Fee: Rs 25800
Parameter Estimation, PopPK & Covariates
  • Fitting strategies & diagnostics
  • FOCEI/SAEM/Bayesian residuals, GOF, VPC bootstrap & shrinkage
  • Population variability & covariates
  • inter-/intra-subject effects age/weight/renal/hepatic DDI & formulation effects
  • Model reporting & reproducibility
  • model file/version control unit tests/simulation checks model/decision cards
Session 4
Fee: Rs 29800
Mini Capstone: Scenario Simulations & Dosing
  • Design simulations for decision support
  • Theory + Practical
  • What-if scenarios & dose optimization
  • DDI, renal/hepatic impairment pediatrics/geriatrics target attainment, PTA/T>MIC
  • Deliverables
  • simulation notebook & config VPC/GOF plots & report dose/regimen recommendation


PDF